![Paige Mahaney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paige Mahaney
Chief Tech/Sci/R&D Officer at
C4 THERAPEUTICS, INC.
Net worth: 412 575 $ as of 31/07/2026
Profile
Paige Mahaney is currently Chief Scientific Officer at C4 Therapeutics, Inc. Formerly, Dr. Mahaney was Senior VP & Corporate Head-Drug Discovery at Exelixis, Inc. Dr. Mahaney earned a doctorate from Massachusetts Institute of Technology and completed undergraduate studies at Guilford College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/02/2026 | 118,556 ( 0.11% ) | 412 575 $ | 31/07/2026 |
Paige Mahaney active positions
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/10/2024 |
Former positions of Paige Mahaney
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Training of Paige Mahaney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Guilford College
 Guilford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Paige Mahaney
